Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Analysis of Contact Traces of Cannabis by In-Tube Solid-Phase Microextraction Coupled to Nanoliquid Chromatography.

Jornet-Martínez N, Ortega-Sierra A, Verdú-Andrés J, Herráez-Hernández R, Campíns-Falcó P.

Molecules. 2018 Sep 15;23(9). pii: E2359. doi: 10.3390/molecules23092359.

2.

EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.

García-Martín A, Garrido-Rodríguez M, Navarrete C, Del Río C, Bellido ML, Appendino G, Calzado MA, Muñoz E.

Biochem Pharmacol. 2018 Nov;157:304-313. doi: 10.1016/j.bcp.2018.07.047. Epub 2018 Aug 2.

PMID:
30076848
3.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E.

Br J Pharmacol. 2018 Oct;175(19):3813-3831. doi: 10.1111/bph.14450. Epub 2018 Aug 23.

PMID:
30033591
4.

Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.

Chelliah MP, Zinn Z, Khuu P, Teng JMC.

Pediatr Dermatol. 2018 Jul;35(4):e224-e227. doi: 10.1111/pde.13545. Epub 2018 May 22.

PMID:
29786144
5.

Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

Fraguas-Sánchez AI, Fernández-Carballido A, Torres-Suárez AI.

Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. Epub 2016 Sep 28. Review.

PMID:
27633508
6.

Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.

Oláh A, Markovics A, Szabó-Papp J, Szabó PT, Stott C, Zouboulis CC, Bíró T.

Exp Dermatol. 2016 Sep;25(9):701-7. doi: 10.1111/exd.13042. Epub 2016 Jun 15.

PMID:
27094344
7.

Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes Remodeling of Extracellular Matrix and Wound Closure Activation.

Styrczewska M, Kostyn A, Kulma A, Majkowska-Skrobek G, Augustyniak D, Prescha A, Czuj T, Szopa J.

Biomed Res Int. 2015;2015:862391. doi: 10.1155/2015/862391. Epub 2015 Aug 4.

8.

Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.

Armstrong JL, Hill DS, McKee CS, Hernandez-Tiedra S, Lorente M, Lopez-Valero I, Eleni Anagnostou M, Babatunde F, Corazzari M, Redfern CPF, Velasco G, Lovat PE.

J Invest Dermatol. 2015 Jun;135(6):1629-1637. doi: 10.1038/jid.2015.45. Epub 2015 Feb 10.

9.

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.

Elbaz M, Nasser MW, Ravi J, Wani NA, Ahirwar DK, Zhao H, Oghumu S, Satoskar AR, Shilo K, Carson WE 3rd, Ganju RK.

Mol Oncol. 2015 Apr;9(4):906-19. doi: 10.1016/j.molonc.2014.12.010. Epub 2015 Jan 19.

10.

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Oláh A, Tóth BI, Borbíró I, Sugawara K, Szöllõsi AG, Czifra G, Pál B, Ambrus L, Kloepper J, Camera E, Ludovici M, Picardo M, Voets T, Zouboulis CC, Paus R, Bíró T.

J Clin Invest. 2014 Sep;124(9):3713-24. doi: 10.1172/JCI64628. Epub 2014 Jul 25.

11.

Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Martinez-Martinez E, Amere M, Gujjar R, Mahadevan A, Desprez PY, McAllister SD.

Br J Pharmacol. 2014 Oct;171(19):4464-77. doi: 10.1111/bph.12803. Epub 2014 Sep 5.

12.

Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.

Emery SM, Alotaibi MR, Tao Q, Selley DE, Lichtman AH, Gewirtz DA.

J Pharmacol Exp Ther. 2014 Feb;348(2):293-302. doi: 10.1124/jpet.113.205120. Epub 2013 Nov 20. Erratum in: J Pharmacol Exp Ther. 2016 Jun;357(3):619.

13.

Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy.

Ward SJ, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA.

Br J Pharmacol. 2014 Feb;171(3):636-45. doi: 10.1111/bph.12439.

14.
15.

Epigenetic control of skin differentiation genes by phytocannabinoids.

Pucci M, Rapino C, Di Francesco A, Dainese E, D'Addario C, Maccarrone M.

Br J Pharmacol. 2013 Oct;170(3):581-91. doi: 10.1111/bph.12309.

16.

Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

Takeda S, Okajima S, Miyoshi H, Yoshida K, Okamoto Y, Okada T, Amamoto T, Watanabe K, Omiecinski CJ, Aramaki H.

Toxicol Lett. 2012 Nov 15;214(3):314-9. doi: 10.1016/j.toxlet.2012.08.029. Epub 2012 Sep 8.

17.

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.

Shrivastava A, Kuzontkoski PM, Groopman JE, Prasad A.

Mol Cancer Ther. 2011 Jul;10(7):1161-72. doi: 10.1158/1535-7163.MCT-10-1100. Epub 2011 May 12.

18.

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.

Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA.

Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9.

19.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

McAllister SD, Murase R, Christian RT, Lau D, Zielinski AJ, Allison J, Almanza C, Pakdel A, Lee J, Limbad C, Liu Y, Debs RJ, Moore DH, Desprez PY.

Breast Cancer Res Treat. 2011 Aug;129(1):37-47. doi: 10.1007/s10549-010-1177-4. Epub 2010 Sep 22. Erratum in: Breast Cancer Res Treat. 2012 May;133(1):401-4.

20.

Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.

Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL.

Drug Dev Ind Pharm. 2010 Sep;36(9):1088-97. doi: 10.3109/03639041003657295.

PMID:
20545522

Supplemental Content

Loading ...
Support Center